Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection

Journal of Hospital Infection

Volumn 83, Issue 4, 2013, Pages 294-299

  Shah, D N ^a,b   Bhatt, N S ^c   Welch, J K ^a   Koo, H L ^b,c,d   Garey, K W ^a,b,c  

^a UNIVERSITY OF HOUSTON   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Clostridium difficile infection; Guideline development; Healthcare associated infections; Severity scoring systems

Indexed keywords

CREATININE;

ACUTE DISEASE; ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNITY ONSET CLOSTRIDIUM DIFFICILE INFECTION; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ONSET CLOSTRIDIUM DIFFICILE INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CREATININE; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; SERUM;

EID: 84875392481     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.12.011     Document Type: Article

References (20)

1. Cohen S.H., Gerding D.N., Johnson S., et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
2. Price M.F., Dao-Tran T., Garey K.W., et al. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect 2007, 65:42-46.
3. Garey K.W., Jiang Z.D., Ghantoji S., Tam V.H., Arora V., Dupont H.L. A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. Clin Infect Dis 2010, 51:1406-1410.
4. Barbut F., Depitre C., Delmee M., Corthier G., Petit J.C. Comparison of enterotoxin production, cytotoxin production, serogrouping, and antimicrobial susceptibilities of Clostridium difficile strains isolated from AIDS and human immunodeficiency virus-negative patients. J Clin Microbiol 1993, 31:740-742.
5. McDonald L.C., Coignard B., Dubberke E., Song X., Horan T., Kutty P.K. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007, 28:140-145.
6. Cheng A.C., Ferguson J.K., Richards M.J., et al. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection. Med J Aust 2011, 194:353-358.
7. Bauer M.P., Kuijper E.J., van Dissel J.T. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009, 15:1067-1079.
8. Bishara J., Peled N., Pitlik S., Samra Z. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. J Hosp Infect 2008, 68:308-314.
9. Khanna S., Pardi D.S., Aronson S.L., et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol 2012, 107:89-95.
10. Gujja D., Friedenberg F.K. Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Therapeut 2009, 29:635-642.
11. Henrich T.J., Krakower D., Bitton A., Yokoe D.S. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 2009, 15:415-422.
12. Lungulescu O.A., Cao W., Gatskevich E., Tlhabano L., Stratidis J.G. CSI: a severity index for Clostridium difficile infection at the time of admission. J Hosp Infect 2011, 79:151-154.
13. Pant C., Madonia P., Minocha A., Manas K., Jordan P., Bass P. Laboratory markers as predictors of mortality in patients with Clostridium difficile infection. J Investig Med 2010, 58:43-45.
14. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
15. Zar F.A., Bakkanagari S.R., Moorthi K.M., Davis M.B. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302-307.
16. Bauer M.P., Hensgens M.P.M., Miller M.A., et al. Renal failure and leucocytosis are predictors of a complicated course of Clostridium difficile infection if measured on day of diagnosis. Clin Infect Dis 2012, 55:S149-S153.
17. Wenisch J.M., Schmid D., Kuo H.W., et al. Hospital-acquired Clostridium difficile infection: determinants for severe disease. Eur J Clin Microbiol Infect Dis 2012, 31:1923-1930.
18. Eddi R., Malik M.N., Shakov R., Baddoura W.J., Chandran C., Debari V.A. Chronic kidney disease as a risk factor for Clostridium difficile infection. Nephrology (Carlton) 2010, 15:471-475.
19. Yousuf K., Saklayen M.G., Markert R.J., Barde C.J., Gopalswamy N. Clostridium difficile-associated diarrhea and chronic renal insufficiency. South Med J 2002, 95:681-683.
20. Stewart D.B., Hollenbeak C.S. Clostridium difficile colitis: factors associated with outcome and assessment of mortality at a national level. J Gastrointest Surg 2011, 15:1548-1555.